Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-001849

Options or other derivatives

  • HEAD OF R&D acquired 930,945 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
MODUR VIJAY HEAD OF R&D 2021-04-01 Grant or award · Restricted Stock Units +174,643 174,643 D
MODUR VIJAY HEAD OF R&D 2021-04-01 Grant or award · Restricted Stock Units +44,683 219,326 D
MODUR VIJAY HEAD OF R&D 2021-04-01 Grant or award · Stock Options (Right to Buy) +711,619 711,619 D
Loading xslF345X03/form4-04022021_060425.xml…